Concert: Sun Pharma completes acquisition of Concert Pharmaceuticals
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
Read full article »
Concert is a Massachusetts-based biopharmaceutical company that researches and develops small-molecule drugs for the treatment of autoimmune diseases.
Read more